Vital Pulp Therapy of Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material
The Effect of Two Different Contemporary Chelating Agents on Vital Pulp Therapy in Mature Permanent Teeth With Irreversible Pulpitis Using Bioceramic Material
1 other identifier
interventional
40
1 country
1
Brief Summary
This clinical trial is designed to study and compare the effect of two different types of chelating agents on the vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2022
CompletedFirst Submitted
Initial submission to the registry
July 8, 2023
CompletedFirst Posted
Study publicly available on registry
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedApril 18, 2024
July 1, 2023
1 year
July 8, 2023
April 17, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Success rate of vital pulp therapy of mature permanent teeth with irreversible pulpitis using bioceramic material.
1. Through post operative pain assessment using Visual analogue scale (0-3) scores as 0 represents no pain, 1= mild pain, 2= moderate pain and 3= sever pain. VAS scores marked at intervals of 2,6,24,48 and 72 hours. 2. Clinical success criteria: Clinical parameters indicating successful treatment include the following criteria: * Absence of pain except for the first 24 hours. * Normal soft tissue around the tooth ( no swelling, no sinus tract).
one year
The Pulp vitality
Pulp vitality will be assessed through pulpal response to thermal and electrical pulp tests. at 3,6,12 months
one year
Secondary Outcomes (1)
Radiographic success
one year
Study Arms (2)
Apple vinegar group
EXPERIMENTALAfter hemostasis of the exposed pulp is achieved, Apple vinegar will be used for dentin conditioning for 5 mins then 1-2 mm thickness of MTA placed on the exposed pulp chamber.
EDTA 17% group
ACTIVE COMPARATORAfter hemostasis of the exposed pulp is achieved, EDTA 17 % will be used for dentin conditioning then 1-2 mm thickness of MTA placed on the exposed pulp chamber.
Interventions
Application of each chelating agent for 5 minutes for dentin conditioning followed by placement of MTA on the pulp chamber.
Eligibility Criteria
You may qualify if:
- Presence of at least one tooth with carious pulp exposure and irreversible pulpitis.
- Cooperative behavior with no medical problem.
- Absence of tooth mobility , tenderness on percussion.
- History of pain with cold and sweets.
- Radiographically, no internal or external resorption, no periapical or furcation radiolucency and no widening of the periodontal membrane space.
You may not qualify if:
- Teeth with pulp necrosis.
- Presence of sinus tract.
- Teeth with open apices.
- Pregnant women.
- History of intolerance of non- steroidal anti inflammatory drugs.
- Tenderness to palpation of adjacent soft tissues
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sinai Universitylead
Study Sites (1)
Mona Rizk Abo El Wafa Ahmed
Cairo, Egypt
Related Publications (1)
Sobh YTM, Ahmed MRA. The effect of two different contemporary chelating agents on vital pulp therapy in mature permanent teeth with irreversible pulpitis using bioceramic material: randomized clinical trial. BMC Oral Health. 2024 Aug 8;24(1):918. doi: 10.1186/s12903-024-04627-6.
PMID: 39118082DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Mona R Abo El Wafa Ahmed, PhD
Faculty of Dentistry, Sinai University.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- double ( participant, outcome assessor)
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
July 8, 2023
First Posted
August 1, 2023
Study Start
December 1, 2022
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
April 18, 2024
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- 2 years